Eric Shaff

Eric Shaff

Chief Executive Officer en SERES THERAPEUTICS, INC. .

Fortuna: 104 738 $ al 31/07/2023

48 años
Health Technology
Consumer Services
Finance

Perfil

Eric D.
Shaff
is currently the President, Chief Executive Officer & Director at Seres Therapeutics, Inc. He previously served as an Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023.
Eric also worked as a Principal at Pfizer Inc. and as the Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011.
Additionally, he held the position of Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014.
Eric started his career as a Senior Analyst at Broadview International LLC.
He completed his undergraduate studies at the University of Pennsylvania and earned an MBA from the Johnson Graduate School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/02/2024 135 321 ( 0.09% ) 104 738 $ 31/03/2024
11/08/2023 0 ( -.--% ) - $ 31/07/2023

Cargos activos de Eric Shaff

EmpresasCargoInicio
SERES THERAPEUTICS, INC. Chief Executive Officer 15/01/2019
Todos los cargos activos de Eric Shaff

Antiguos cargos conocidos de Eric Shaff.

EmpresasCargoFin
SIGILON THERAPEUTICS, INC. Director/Board Member 11/08/2023
MOMENTA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/11/2014
Corporate Officer/Principal 01/12/2011
PFIZER, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Eric Shaff.

Formación de Eric Shaff.

University of Pennsylvania Undergraduate Degree
Johnson Graduate School of Management Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Eric Shaff.

Relaciones

100 +

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
PFIZER, INC.

Health Technology

SERES THERAPEUTICS, INC.

Health Technology

SIGILON THERAPEUTICS, INC.

Health Technology

Empresas privadas3

Health Technology

Health Technology

Finance

Ver las conexiones de la empresa